Global Distribution Planned for Military-Grade Portable Oxygen Concentrator.
Ball Ground, GA (January 15, 2021) – Global oxygen therapy manufacturer CAIRE Inc. announced today the launch of the SAROS™ 4000 Oxygen System, a proprietary portable oxygen concentrator designed specifically for military use.
The newly-updated, CE-marked SAROS meets the state-of-the-art medical device standards for the European Economic Area and comes equipped with CAIRE’s proprietary technology, autoSAT®, providing the ability to consistently maintain oxygen saturation by adjusting to the patient’s respiratory rate and deliver up to 3 liters per minute of oxygen therapy to the user.
“This rugged device incorporates cutting-edge clinical technology to reliably service injured military servicemen and women and is built to endure the rigors of use in harsh environments,” said Earl Lawson, CAIRE President, and CEO. “With the addition of the CE-mark to this oxygen therapy solution, the SAROS 4000 will have expanded use throughout Europe and beyond.”
The SAROS 4000 predecessor, the SAROS 3000 was introduced in 2011 following a research and development partnership with the United States Army. The first of its kind, the SAROS is an alternative to oxygen cylinders to provide life-saving oxygen during transport off the battlefield.
Weighing 12.3 lbs. (5.56 kg) with a rechargeable battery, the device is designed to eliminate the safety concerns associated with conventional oxygen cylinders on military transport vehicles and to increase operations efficiency by eliminating the need to monitor and replenish oxygen tank supplies.
The SAROS can deliver up to 3000 mL of oxygen per minute thanks to powerful air separation technology — Vacuum Pressure Swing Adsorption (VPSA). CAIRE’s division, AirSep, has to lead the way in developing this technology which offers the most efficient way to remove residual nitrogen while delivering high purity oxygen to the user.
This delivery combined with proprietary clinical features including autoSAT, Body, Temperature, and Pressure (BTP) flow compensation, and Adjustable Pulse Sensitivity ensure patients, even those with a weak inspiratory effort, get the oxygen they need in the most efficacious way possible.
The SAROS 4000 is available exclusively through ZOLL Medical Corporation outside the United States.
For more information, visit www.caireinc.com.
CAIRE Inc. leverages its rich legacy in oxygen technology expertise to develop and market innovative solutions in support of the long-term health and wellness of people with chronic respiratory conditions, as well as industrial applications to benefit the commercial enterprise. Our time-proven portfolio of brands includes respiratory care diagnostic equipment; oxygen therapy devices designed for portable, at-home and military use; and turnkey on-site generation solutions for medical, industrial, and environmental applications. With its global manufacturing headquarters in Ball Ground, GA, USA, CAIRE employs approximately 600 employees with sales and services in more than 100 countries. Read more CAIRE news at www.caireinc.com.